Literature DB >> 15385527

Oral immunization with a combination of Plasmodium yoelii merozoite surface proteins 1 and 4/5 enhances protection against lethal malaria challenge.

Lina Wang1, Matthew W Goschnick, Ross L Coppel.   

Abstract

Oral immunization of mice with Escherichia coli-expressed Plasmodium yoelii merozoite surface protein 4/5 or the C-terminal 19-kDa fragment of merozoite surface protein 1 induced systemic antibody responses and protected mice against lethal malaria infection. A combination of these two proteins administered orally conferred improved protection compared to that conferred by either protein administered alone.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15385527      PMCID： PMC517577          DOI： 10.1128/IAI.72.10.6172-6175.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  12 in total

1.  Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells.

Authors:  C Hirunpetcharat; J H Tian; D C Kaslow; N van Rooijen; S Kumar; J A Berzofsky; L H Miller; M F Good
Journal:  J Immunol       Date:  1997-10-01       Impact factor: 5.422

2.  Immunization with recombinant Plasmodium yoelii merozoite surface protein 4/5 protects mice against lethal challenge.

Authors:  L Kedzierski; C G Black; R L Coppel
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice.

Authors:  T M Daly; C A Long
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

Review 4.  Immune effector mechanisms in malaria.

Authors:  M F Good; D L Doolan
Journal:  Curr Opin Immunol       Date:  1999-08       Impact factor: 7.486

5.  Immunization with a combination of merozoite surface proteins 4/5 and 1 enhances protection against lethal challenge with Plasmodium yoelii.

Authors:  Lukasz Kedzierski; Casilda G Black; Matthew W Goschnick; Anthony W Stowers; Ross L Coppel
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

6.  Immunization against Plasmodium chabaudi malaria using combined formulations of apical membrane antigen-1 and merozoite surface protein-1.

Authors:  James M Burns; Patrick R Flaherty; Margarita M Romero; William P Weidanz
Journal:  Vaccine       Date:  2003-05-16       Impact factor: 3.641

7.  Genetic regulation of protective immune response in congenic strains of mice vaccinated with a subunit malaria vaccine.

Authors:  J H Tian; L H Miller; D C Kaslow; J Ahlers; M F Good; D W Alling; J A Berzofsky; S Kumar
Journal:  J Immunol       Date:  1996-08-01       Impact factor: 5.422

8.  Intranasal immunization with yeast-expressed 19 kD carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (yMSP119) induces protective immunity to blood stage malaria infection in mice.

Authors:  C Hirunpetcharat; D Stanisic; X Q Liu; J Vadolas; R A Strugnell; R Lee; L H Miller; D C Kaslow; M F Good
Journal:  Parasite Immunol       Date:  1998-09       Impact factor: 2.280

9.  Immunization against malaria with a recombinant protein.

Authors:  I T Ling; S A Ogun; A A Holder
Journal:  Parasite Immunol       Date:  1994-02       Impact factor: 2.280

Review 10.  Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants.

Authors:  H Daniell; S J Streatfield; K Wycoff
Journal:  Trends Plant Sci       Date:  2001-05       Impact factor: 18.313
View more
  5 in total

1.  Genetic diversity of the Plasmodium vivax merozoite surface protein-5 locus from diverse geographic origins.

Authors:  Chaturong Putaporntip; Rachanee Udomsangpetch; Urassaya Pattanawong; Liwang Cui; Somchai Jongwutiwes
Journal:  Gene       Date:  2010-02-21       Impact factor: 3.688

2.  Induction of strain-transcending immunity against Plasmodium chabaudi adami malaria with a multiepitope DNA vaccine.

Authors:  T Scorza; K Grubb; P Smooker; A Rainczuk; D Proll; T W Spithill
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

3.  Growth-inhibitory antibodies are not necessary for protective immunity to malaria infection.

Authors:  E Elsa Herdiana Murhandarwati; Lina Wang; Harini D de Silva; Charles Ma; Magdalena Plebanski; Casilda G Black; Ross L Coppel
Journal:  Infect Immun       Date:  2009-11-16       Impact factor: 3.441

4.  A Synthetic Nanoparticle Based Vaccine Approach Targeting MSP4/5 Is Immunogenic and Induces Moderate Protection Against Murine Blood-Stage Malaria.

Authors:  Kirsty L Wilson; Dodie Pouniotis; Jennifer Hanley; Sue D Xiang; Charles Ma; Ross L Coppel; Magdalena Plebanski
Journal:  Front Immunol       Date:  2019-03-15       Impact factor: 7.561

5.  Needle-free, spirulina-produced Plasmodium falciparum circumsporozoite vaccination provides sterile protection against pre-erythrocytic malaria in mice.

Authors:  Tracy Saveria; Chaitra Parthiban; Annette M Seilie; Colin Brady; Anissa Martinez; Ridhima Manocha; Esha Afreen; Hui Zhao; Ashley Krzeszowski; Jeremy Ferrara; Troy Paddock; James Roberts; Brad C Stone; Michael Tasch; Sean C Murphy
Journal:  NPJ Vaccines       Date:  2022-10-04       Impact factor: 9.399
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.